Jeffrey Kroin to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Jeffrey Kroin has written about Dose-Response Relationship, Drug.
Connection Strength
0.482
-
Effect of acute versus continuous glycemic control on duration of local anesthetic sciatic nerve block in diabetic rats. Reg Anesth Pain Med. 2012 Nov-Dec; 37(6):595-600.
Score: 0.097
-
Upregulation of cerebrospinal fluid and peripheral prostaglandin E2 in a rat postoperative pain model. Anesth Analg. 2006 Aug; 103(2):334-43, table of contents.
Score: 0.063
-
Clonidine prolongation of lidocaine analgesia after sciatic nerve block in rats Is mediated via the hyperpolarization-activated cation current, not by alpha-adrenoreceptors. Anesthesiology. 2004 Aug; 101(2):488-94.
Score: 0.055
-
Postoperative pain and analgesic responses are similar in male and female Sprague-Dawley rats. Can J Anaesth. 2003 Nov; 50(9):904-8.
Score: 0.052
-
Continuous intrathecal clonidine and tizanidine in conscious dogs: analgesic and hemodynamic effects. Anesth Analg. 2003 Mar; 96(3):776-782.
Score: 0.050
-
Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg Anesth Pain Med. 2002 Sep-Oct; 27(5):451-5.
Score: 0.048
-
Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg. 2000 Apr; 90(4):913-7.
Score: 0.041
-
Intrathecal clonidine and tizanidine in conscious dogs: comparison of analgesic and hemodynamic effects. Anesth Analg. 1996 Mar; 82(3):627-35.
Score: 0.031
-
Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth Analg. 2004 Nov; 99(5):1453-1460.
Score: 0.014
-
Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res. 1984; 54(1):191-4.
Score: 0.013
-
Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg. 1998 Apr; 86(4):830-6.
Score: 0.009
-
Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery. 1997 Jan; 40(1):94-9; discussion 99-100.
Score: 0.008